Lv7
4980 积分 2020-12-17 加入
Preclinical characterization and comparison between CD3/CD19 bispecific and novel CD3/CD19/CD20 trispecific antibodies against B-cell acute lymphoblastic leukemia: targeted immunotherapy for acute lymphoblastic leukemia
9小时前
待确认
A bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trial
9小时前
已完结
High-affinity omalizumab variants with optimized disruptive potency prevent anaphylaxis in vivo
14天前
已完结
POS0017 Bispecific T Cell-Engaging Antibodies to Target TRBV9+ Autoreactive T Cells in Axial Spondyloarthritis
14天前
已完结
Selective depletion of ABO-responsive B cells by T-cell–engaging bispecific antibody conjugates for ABOi transplantation
16天前
已完结
mRNA-LNP therapeutics for obesity: weight loss with metabolic repair
21天前
已完结
CAR-T cells generated in vivo for the targeted treatment of myocardial fibrosis
1个月前
已完结
Nanobody-based microfluidic human Fc assay for preclinical plasma quantification of IgG1/1.1 and IgG1-Fc-conjugates
1个月前
已完结
Expansion of platform physiologically-based pharmacokinetic model for monoclonal antibodies towards different preclinical species: cats, sheep, and dogs
1个月前
已完结
Modifications of the human urocortin 2 peptide that improve pharmacological properties
1个月前
已完结
皖公网安备34019202002308
